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    ABSTRACT
     THE EXPRESSION OF BCL-2 FAMILY OF GENES DURING LIVER
  REGENERATION
      Ahmet UCAR
M.S. in Molecular Biology and Genetics
Supervisor: Assist. Prof. Kamil Can Akcali
September 2001
Hepatic regeneration is a process that includes cellular proliferation and cellular
death. Apoptosis is the main tool for the organism to control the death in order to
prevent the destruction of the tissues, and maintain the homeostasis. The main
regulators of apoptotic machinery are the Bcl-2 family proteins, which act mainly on
mitochondrial control of death pathway. We used both 40% and 70% partial
hepatectomy groups, and investigated the expression patterns of bcl-2 family
members (bcl-2, bcl-xL, bcl-w, bax, bak, bid, and mtd) in transcript levels within a
time spectrum that extends to 14 days, which is required for the completion of the
regeneration process. We used semi-quantitative PCR technique, and compared the
results with the sham operation groups as a negative control. With this comparison,
we were able to understand the regeneration-induced changes in transcript levels of
the genes studied. Our results demonstrated that, the regeneration process had a
time-dependent and tight regulation in the 70% partial hepatectomy groups, whereas
this was not the case for 40%. However, we also found that surgery itself caused
changes in the expression of these genes. Therefore, we think that these changes
might not only due to regeneration, but also due to surgery.
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ÖZET
KARACİĞER REJENERASYONU SIRASINDA BCL-2 GEN AİLESİ
   ÜYELERİNİN EKSPRESYONLARI
         Ahmet UCAR
Moleküler Biyoloji ve Genetik Yüksek Lisans
Tez yöneticisi: Yard.Doç.Dr. Kamil Can Akçalı
         Eylül 2001
Karaciğerde rejenerasyon mekanizması hücre bölünmelerini ve ölümlerini içerir.
Apoptozis, programlı hücre ölümü, organizmanın kendi dengesinin bozulmasını
engelemek amacıyla kullandığı en önemli araçtır. Apoptozis mekanizmasının
kontrolü, temel olarak mitokondri üzerinden fonksiyon gösteren Bcl-2 protein ailesi
üyelerince yapılır. %40’lık ve %70’lik kısmi karaciğer rezeksiyonu gruplarında bcl-
2 gen ailesi üyelerinin (bcl-2, bcl-xL, bcl-w, bax, bak, bid, ve mtd) mRNA
ekspresyonlarını, rejenerasyonun tamamlanması için gerekli olan ameliyattan
sonraki 14 güne kadar uzanan bir zaman dilimi içinde inceledik. Semi-quantitative
PCR tekniğini kullanarak elde edilen sonuçları kontrol grubu olarak hazırladığımız
sham operasyonu yapılmış grupların sonuçları ile karşılaştırdık. Buna göre %40’lık
kısmi karaciğer rezeksiyonu gruplarında rejenerasyon olayının, %70’liklerde olduğu
gibi zamana bağlı olarak sıkı kontrol edilmediğini saptadık. Ancak cerrahi
operasyonun kendi başına bizim incelediğimiz genlerde önemli seviyelerde
ekspresyon değişimlerine sebep olduğundan %70’lik gruplardaki ekspresyon
değişimlerinin sadece rejenerasyon olayından dolayı değil, aynı zamanda ameliyatın
etkilerinden dolayı da kaynaklandığını düşünmekteyiz.
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11. INTRODUCTION
21.1. Liver as an organ
Liver is the largest organ in the body and has a central role in metabolic
functions that are essential for survival.
Liver is developmentally derived from the endoderm. The hepatic diverticulum
is the tube of endoderm that extends out from the foregut into the surrounding
mesenchyme. And mesenchyme induces this endoderm to proliferate, branch and
form the glandular epithelium of the liver during early organogenesis (Gilbert S.F.,
2000).
The functional basic unit of the liver is the lobule.  The lobule is composed of
many hepatic cellular plates that radiate centrifugally from the central vein like
spokes in a wheel. Each hepatic plate is usually two cells thick, and between the
adjacent cells lie small bile canaliculi that empty into bile ducts in the fibrious septa
separating the adjacent liver lobules (Guyton and Hall, 1996).
The major cell type in the liver is hepatocytes that are called as parenchyme
cells. The %80 of the liver is composed of hepatocytes and has less differentiated
cells compared to the other organs. These features make liver a perfect system to
work on organogenesis.
 But other than the vascular structures and hepatocytes, there are typical
endothelial cells and large Kupffer cells, which lined through the venous sinusoids.
They are referred as non-parenchyme cells. Kupffer cells are type of macrophages
that are capable of phagocytizing bacteria and other foreign matter in the hepatic
sinus blood. Also the lymphatic system is connected to the system through the tissue
structures called space of Disse (Guyton and Hall, 1996).
A defect in the liver’s function can not be replaced by any other organ.
Although, liver is not a proliferative organ in normal cases, it responds to alterations
3in order to correct the defects in its functions. That’s why, during evolution liver
gained a high capacity of regeneration.
The basic functions of liver can be categorized such as; (1) endocrine functions;
(2) digestive functions; (3) metabolic functions; and (4) excretory and degradetive
functions (Guyton and Hall, 1996; Vander et.al., 1994).
Major endocrine functions of the liver are as follows; it secretes insulin-like
growth factor-I , which promotes growth by stimulating mitosis in various tissues,
including bone; it contributes to the activation of Vitamin D; it secretes
angiotensinogen, which is acted upon by renin to form angiotensin; and  it
metabolizes most of the hormones.
Liver has important functions in digestive physiology. It synthesizes and
secretes bile acids, which are necessary for adequate digestion and absorption of fats.
In addition, liver secretes a bicarbonate-rich solution of inorganic ions into the bile,
which helps neutralize acid in the duodenum (Guyton and Hall, 1996).
Liver has several metabolic functions concerned with the majority of the
metabolic systems of the body. It converts the plasma glucose into glycogen and
triacylglycerols during absorptive period; converts plasma amino acids to fatty acids,
which can be incorporated into triacylglycerols during absorptive period; converts
fatty acids into ketones during fasting; synthesizes cholesterol and releases it into the
blood; and secretes plasma cholesterol into the bile (Vander et.al., 1994).
Liver secretes bilirubin and other bile pigments into the bile and via the bile, it
excretes many endogenous and foreign organic molecules as well as trace metals. It
functions also in destroying old erythrocytes.
4 All the iron in the body is stored in liver in addition to the erythrocytes within
the structure of hemoglobin. Also liver filtrates the blood coming from intestines,
which is contaminated by many bacteria and other foreign organisms.
1.2.   Liver regeneration
1.2.1.History of studies on liver regeneration
The first mention of hepatic regeneration can be traced to the Greek legend of
Prometheus. However, it was only toward the end of the 19th century that the first
experimental observations were performed on laboratory animals. In these studies,
they demonstrated complete restoration of hepatic mass following either a partial
hepatectomy (PH) or a sub lethal hepatic injury induced by chloroform (Von
Podwyssozki, 1886; Ponfick, 1890).
A landmark event in the field of hepatic regeneration occurred when Higgins
and Anderson (1931) standardized the procedure of partial hepatectomy using rat.
This model rapidly became the most frequently utilized in vivo system to examine
the process of liver regeneration. The second series of landmark observations in this
field were done by  Christensen and Jacobsen (1949), Bucher et al.(1951), and Fisher
et al.(1971) by utilizing parabiotic rats. And also by using autografts, Leong et
al.(1964) and Segal et al.(1968) have found out that the factors initiating the process
of hepatic regeneration are blood borne. Earlier experimental studies by Teir and
Ravanti (1953) and Blomqvist (1957), which suggested that the factors initiating the
hepatic regeneration might be synthesized by the liver itself, led to a variety of
theories concerning the regulation of hepatic regeneration. The most important of
these theories suggested the existence of both growth stimulating factors (GSFs) and
5growth inhibiting factors (GIFs). After that, many attempts have been made during
1970’s and 1980’s to isolate both kinds of these factors.
The most popular alternative hypotheses to the concept of GSFs and GIFs
concerning the regulation of hepatic regeneration were (1) the metabolic overload
theory (Goss, 1964; Alston and Thomson, 1966), in which the liver was believed to
increase its mass to satisfy a specific need, and (2) the blood flow theory (Mann,
1944; Child et al., 1953; Weinbrein et al., 1975), in which the amount of blood
delivered to the liver, particularly via the portal vein, determined the hepatic mass.
Insulin was recognized as an important hepatothrophic substance responsible for
liver regeneration in the studies, which are directed at assessing the latter hypothesis
(Starzl et.al.1976). And this finding represents the third landmark in the long history
of hepatic regeneration and its control. Several hormones other than insulin were also
shown to have some affect in stimulating liver regeneration, although not as much as
insulin.
In the mid-1970’s, the development of the primary hepatocyte cultures
provided an important new in vitro model for the study of hepatic regeneration under
highly controlled laboratory conditions (Leffert et al., 1978; Maher, 1988). Using cell
culture systems, it was quickly noted that the processes regulating liver cell growth
observed in vivo and those noted in vitro were different, presumably because liver
cells in culture lack the complex interactions which occur in vivo between
hepatocytes and non-parenchymal cells (Fraslin et.al., 1985). Some other studies also
demonstrated that the critical interactions also occur between liver cells and the
matrix upon which the liver cells were plated, and that these interactions influence
the functional and replicative activity of hepatocytes maintained in the culture
(Bissell and Choun, 1988).
6In the 1980’s, the techniques of molecular biology had allowed the
investigators to define more clearly the molecular events occurring in proliferating
hepatocytes, like alterations in oncogene expression, the timing of growth factor and
hormone expression and both qualitative and quantitative changes in the intracellular
content of proteins that are important in the process of cell growth and replication.
In 1990’s, with the accumulation of knowledge about the involvement of
rapidly growing spectrum of genes tested in the control of liver regeneration, many
hypothesis and theories were generated. With the development of transgenic and
knock-out technologies, several of the genes, whose expression was shown to be
changing during the regeneration of liver, were tested for the significance of these
genes (Fausto et.al.,1999).
 
1.2.2. Kinetics of hepatic regeneration
Under normal circumstances, the proliferative activity of hepatocytes in adults
is very low, and only a few cells can be shown to proliferate. These proliferating
cells are typically found near the portal tracts, closer to the incoming portal blood
(Grisham, 1962).
For rats, in normal conditions, the labeling index of hepatocytes 2hr after an i.p.
administration of [3H]-thymidine is 0.3% (Grisham, 1962; Edwards and Koch, 1964).
Under steady-state conditions, non-parenchymal cells have even lower proliferation
rates than that observed for hepatocytes. After 60 hr of continuous administration of
[3H]-thymidine, Kuppfer cells and endothelial cells have a labeling index of only 3
and 7%, respectively, for rats (Bouwens et.al., 1986).
However, when a surgical resection or hepatic injury, induced either by a viral
illness or chemical injury that reduces the functional mass of the liver, these
7proliferation rates change very dramatically. During the regenerative response that
follows any major hepatic injury, virtually all of the surviving hepatocytes undergo
mitosis. In fact, if the residual liver of a partially hepatectomized rat is infused with
[3H]-thymidine for the 7 to 8 day required for the hepatic mass to be restored fully,
95% of the liver cells will be found to contain the label (Sell, 1990; Fausto, 1990).
In rats, the hepatic regenerative response following partial hepatectomy starts
in an almost synchronous manner in the peripheral part of the lobule, producing a
peak of DNA synthesis after about 18hr. Almost all the remaining hepatocytes of the
liver progressively proliferate (Rabes et. al., 1975; Bucher and Malt, 1971). And
these observations suggest that under physiological conditions resting hepatocytes
are arrested in the G0 phase of the cell cycle (Bucher and Malt, 1971). After a partial
hepatectomy in rats, hepatocyte DNA synthesis starts after a lag phase of 12hr and
reaches a peak within 6hr. In contrast, the peak mitotic activity of non-parenchymal
cells is delayed, and occurs at 48hr and 96hr (Widmann and Fahimi, 1975).
A post-hepatectomy-induced proliferative response leads to full restoration of
the hepatic mass in rats in about 10 days. For larger animals and man, full restoration
of hepatic mass requires a longer period of time like 2 or 3 weeks (Bucher and Malt,
1971; Fausto et.al., 1986).
The kinetics of hepatic regeneration described above are those observed in
young adult animals. In weanling rats, the peak of DNA synthesis is achieved 3hr
earlier, while in older rats it is delayed by about 5hr (Bucher et al., 1964). Moreover,
a regenerative response occurs, when at least 30% of the liver mass is removed in
young adult rats. In very young and in aged rats, a 10% reduction also suffices to
trigger a regenerative response probably because the functional reserve of the liver is
different for each of these age groups (Bucher et al., 1964). The proliferative
8response is influenced also by the feeding or light exposure pattern of the animal as
both of these factors modulate the circadian rhythms of the animals (Bucher and
Malt, 1971).
1.2.3. Extracellular factors in control of hepatic regeneration.
Many factors have been identified in the control of hepatic regeneration. These
are mainly categorized in two groups as hormones and growth factors.
Numerous changes in circulating hormone levels have been reported in rats
following PH. Many of these changes have been characterized and appear to
correlate with measurable alterations in the hepatocyte expression of receptors for
these hormones. However, in vitro only some of them can be shown to amplify the
proliferative response when added to a culture system containing medium with these
growth factors. The significance of the findings were almost certain since their
effects were confirmed either by using the anti-hormone drugs, chemicals or
peptides, or by the removal of the organ responsible for the production and excretion
of that hormone into the bloodstream.
In very different experimental setups, insulin and glucagon were shown to be
very critical for the control of the hepatic regeneration (Thrower and Ord, 1974;
Yaunger et.al., 1966). Although insulin does not stimulate hepatocyte proliferation
directly in vitro, its effect on hepatocyte proliferation appears to depend upon its
metabolic effects. The precise role of the glucagon in the process remains also
controversial because of the difficulties encountered in defining its role, either alone
or in conjunction with insulin, as a hepato-proliferative factor (Caruana et.al., 1981).
Following a PH, striking alterations in the blood levels of sex hormones occur
and accompanying changes in the hepatic content of sex hormone receptors appear
9within the liver. Serum estradiol levels increase, while the hepatic content of
estrogen receptors also increases. In contrast, serum androgen levels decline in
concert with a rapid disappearance of androgen receptors within the liver. These
changes in the hormone receptor level in the liver occur only in male rats, and are
accompanied by a reduction in the hepatic levels of other testosterone-inducible
enzymes that metabolize estrogens. This process of the increase in serum estradiol
level, an increase of estrogen receptor and a reduction of estradiol metabolizing
enzyme system has been termed hepatic ”feminization” and appears to be a critical
step in the overall process of hepatic regeneration for male animals (Eagon
et.al.,1985; Francavilla et.al., 1986).
Thyroid hormone, norepinephrine, and vasopressin were also demonstrated to
be critical for the control of the hepatic regeneration in rats. Thyroidectomy results in
a reduction of regenerative response to a PH, when performed 7 days prior to PH
(Canzanelli et.al. 1949). And just 2 hr after a PH, the blood levels of norepinephrine
shown to be increased substantially (Cruise et.al., 1987). Both in vitro and in vivo,
vasopressin was shown to act synergistically with other hormones to promote
hepatocyte DNA synthesis. Furthermore, the regenerative response following PH
was shown to be impaired in the Battleboro rat, which is vasopressin-deficient, and
exogenous administration of vasopressin to these rats enhances the hepatic
regenerative response to PH (Russell and Bucher, 1983).
The hypothesis that hepatic regeneration is under the control of specific growth
factors has stimulated considerable effort toward the identification and isolation of
such factors. Hepatocyte Growth Factor (HGF), Hepatopoietin B (HPTB), Heparin
Binding Growth Factor-1 (HBGF-1), Transforming Growth Factor-α (TGF-α),
Epidermal Growth Factor (EGF), Hepatic Stimulating Substance (HSS),
10
Cyclosporin, and FK 506 were the well-identified growth stimulating factors that are
involved in the control of the hepatic regeneration. On the other hand, the growth
inhibiting factors, which were identified in the same process, were Transforming
Growth Factor-β (TGF-β), Kupffer Cell Hepatocyte Inhibitor (KCHI), Hepatocyte
Proliferation Inhibitor, Interleukin-1 (IL-1), Interleukin-6 (IL-6), and Tumor
Necrosis Factor (TNF), Nitric Oxide (NO) (reviewed in Francavilla et.al., 1993).
1.2.4. Liver regeneration & apoptosis
Liver regeneration was thought mainly a proliferation process. However, now it
is surely known that, apoptosis is also involved in the process of hepatic regeneration
for hepatic tissue remodeling and in fine-tuning the regenerative response (Fan G.
et.al.,1998; Kren B.T., 1997). The cell division cycles just after the PH are very
rapid, and apoptosis has an important role to eliminate the cells that gain a genetic
defect during these cellular divisions. TUNEL assay showed that a noticeable wave
of apoptosis swept through the livers starting at 60 hours after PH and increased at 72
and 96 hours (Sakamoto T. et.al., 1999).
It is clear that, apoptosis and the cellular proliferation are the two opposing
mechanisms for the fine-tuning of the liver size.
1.3.  Cell death: Apoptosis and necrosis
There are two main types of cell death in living multicellular organisms,
including mammalians. The first one is the apoptosis, as a programmed cell death.
And the second one is the necrosis, which is an un-programmed (accidental) cell
death.
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Apoptosis is a process that is used by the cells in a multicellular organism in
order to keep the homeostasis of the whole organism. All types of cells can undergo
apoptosis as a response to some external or internal death-stimuli. During the
embryologic development, apoptosis is one of the major processes in determining the
tissue morphology and in creating the neural and vascular network of the body. This
process of cellular suicide is also very important in eliminating the cells that have
some genetic mistakes or that are infected by viruses or parasites.
The mechanism and the reasons of apoptosis and necrosis are very different as
well as their consequences. They differ in the extent to which death occurs as a
gradual or ordered process that is minimally disruptive to the tissue (apoptosis), or as
a more abrupt and overwhelming event that is more likely to elicit a substantial
inflammatory response (necrosis) (Kockner, 2001).
During necrosis, the cell swells, its mitochondria dilate, other organelles
dissolve and the plasma membrane ruptures, releasing the cytoplasmic content; this
is what elicits an inflammatory response (Desagher and Martinou, 2000).
Apoptosis induces a characteristic morphology that includes cell shrinkage,
membrane blebbing and chromatin condensation. These microscopic features are
associated with the changes in mitochondrial function and phosphatidyl-serine
display on the outer leaflet of the cytoplasmic membrane. Fragmentation of the DNA
and increased plasma membrane permeability follows in the process. Apoptotic
bodies are formed in the end of this process. They contain the remains of the dead
cells within an altered but the intact plasma membrane and undergo phosphatidyl-
serine-induced phagocytosis by neighboring cells (Desagher and Martinou, 2000).
Since apoptosis has the logic of “to be or not to be”, its cellular and
intracellular regulation is very strict and complicated. The disruption in this
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regulation system results in many pathological conditions. These diseases can be
categorized in two groups based on the direction of dysfunction. If the cells undergo
apoptosis unnecessarily, many degenerative diseases and autoimmune diseases can
occur. Most seen degenerative diseases are the neurodegenerative diseases, since the
lost cells can not be compensated by the remaining neural cells.  In the second group
of diseases, the cells do not undergo apoptosis by losing responsiveness to the
apoptotic stimuli. The most common example is the cancer.
1.3.1. Apoptosis: An evolutionary conserved mechanism.
Apoptosis as a cellular death program has been conserved through evolution, at
least since the appearance of the nematodes. The striking homology between the
cellular participants in apoptosis seen in the nematode Caenorhabditis elegans, in the
fly Drosophilae melanogaster and in the mammalians demonstrate this evolutionary
conservation. The three most important proteins for the apoptosis in C. elegans are
Ced 9, Ced 4, and Ced3. Bcl-2 protein is the mammalian homologue of the Ced 9,
and Apaf-1 and Caspase 9 are homologues of Ced 4 and Ced 3, respectively
(Hengartner, 1998; Newton and Strasser, 1998).
1.3.2. Apoptotic pathways
Apoptosis involves the participation of several cell constituents. These include
members of the Tumor Necrosis Factor (TNF) plasma membrane ‘death receptor’
family, especially Fas and TNF receptor 1 (TNFR1); mitochondria, where
Cytochrome c is released and shown to be very important in many systems; pro- and
anti-apoptotic members of the Bcl-2 protein family; and a group of the cysteine
13
proteases (Caspases) that cleave specific protein substrates at selected aspartate
residues.
1.3.2.1. Death receptors
The death receptor Fas (CD 95) is expressed on the surface of hepatocyes and
many other cell types. And the Fas ligand (FasL, or CD95L) is usually expressed on
the cellular surface of the immunocytes such as cytotoxic lymphocytes. This FasL
enables these cells interact with and kill the target cells by activating their Fas signal
cascade. Fas-FasL interaction causes the trimerization of the Fas in the target cell,
which means the aggregation of the death domains in their cytoplasmic tails and the
formation of a death-inducing signaling complex (DISC). Then the Pro-caspase 8 is
recruited and activated by this complex. The activated Caspase 8 then activates the
caspase cascade (Ashkenazi and Dixit, 1998; Kanzler and Galle, 2000).
TNFR 1 resembles Fas structurally, but the signaling pathways it initiates is
more complex when compared with Fas. Interaction of the TNF-α with the TNFR 1
may activate a similar sequence of events leading to cell death, but the interaction
also has the ability to generate a survival signal via a TNFR 1-initiated kinase
cascade that contains Nuclear Factor-κB (NF-κB), Phophatidyl Inositol-3-Kinase
(PI3K) and Akt/protein Kinase B (PKB). The mechanism by which TNFR 1 chooses
between survival and death signaling is not fully understood, yet (Ashkenazi and
Dixit, 1998; Kanzler and Galle, 2000).
1.3.2.2. Mitochondria.
Several changes may occur in the mitochondria with the apoptosis. As an early
event, the voltage-dependent anion channel (VDAC) complex may be disrupted and
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converted to the permeability transition pore (PTP). This critical transition is
influenced by the pro- and anti-apoptotic members of the Bcl-2 family. The opening
of the PTP leads to collapse of inner mitochondrial membrane potential (∆ψm),
compromising or arresting ATP generation. This, in turn, is associated with
decreased intra-mitochondrial thiols and increased oxidative stress (Gross et.al.,
1999).
In addition to these changes in the mitochondrial energetic, Cytochrome c, the
Apoptosis-Inducing Factor (AIF), and Procaspases 2, 3, and 9 are translocated from
the mitochondrial intermembrane space to cytosol. These proteins are too large to
pass through the PTP, which is limited to molecules not larger than 1.5 kDa.
Translocation could reflect the outer membrane rupture during mitochondrial
swelling, but this does not always occur. Recent evidences suggest hetero-
oligomerization, which would form a sufficiently large pore, between Bid and Bak
(Wei M.C. et.al. 2000) or between VDAC and Bax (Shimizu S. et.al. 2000).
Whatever the mechanism, translocation of the Cytochrome c has two critically
important effects; its loss disrupts the electron transport chain beyond complex III,
and its entry into the cytosol activates the caspase cascade via the formation of the
apoptosome complex. This cytosolic complex consists of Cytochrome c, APAF-1,
Procaspase-9, and either ATP or dATP. The apoptosome cleaves and activates the
Procaspase-9, which then activates Caspase-3 and thus downstream effector
caspases. In addition the Caspase-3 may be activated directly by AIF, which is
released from the mitochondria (Tsujimoto and Shimizu, 2000; Green and Reed,
1998; Adrain and Martin, 2001).
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1.3.2.3. Caspase cascade.
Caspases (cysteine aspartic-acid specific proteases) are typically found in cells
as inactive precursors (zymogens). These procaspases can be activated by caspase
mediated cleavage. Proteolysis releases two fragments of ~20 kDa and ~10kDa that
are assembled into the active tetrameric enzyme (Thornberry and Lazebnik, 1998;
Goyal, 2001).
Caspases implicated in apoptosis can be broadly grouped into initiator or
effector caspases, depending on the role they play within the cell-death machinery.
Initiator caspases are the first to be activated in response to an apoptotic stimulus and
are responsible for activating the effector caspases. The effector caspases, primarily
Caspases-3, -6, and –7, are thought to be responsible for the majority of substrate
proteolysis observed during apoptosis (Thornberry and Lazebnik, 1998).
After the activation of the Caspase 9 via the apoptosome complex, Caspase 9
activates the Caspase 7 and Caspase 3. The active Caspase 3 then activates the
Caspases 6 and 2, finally the active Caspase 6 activates the Caspases 8 and 10
(Goyal, 2001).
Caspases cause the cell death by degrading critical structural elements, such as
lamins and gelsolin, and by activating latent enzymes, such as DNases, through
proteolysis of their inhibitors ( Goyal, 2001).
1.3.3. Apoptosis in liver pathology
It is estimated that in liver only 1-5 per 10 000 cells will be detected as
apoptotic under physiological conditions. Adaptive and hyperplastic liver growth is
usually accompanied by a relatively low rate of apoptosis. Removing the
hyperplastic stimulus results in a dramatic increase in apoptosis in all zones of the
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liver acinus, preferentially in resting or G0 hepatocytes, leading to removal of
excessive hepatocytes. The size of the liver and the degree of the apoptotic cell death
are also determined by the composition and the quantity of the food consumed. Food
restriction cause to the reduction of liver cell mass and cell loss by apoptosis.
Additionally, it has been reported that the rate of the apoptosis is higher at the end of
the daily light (fasting) period than at the end of the night (feeding) period ( Kanzler
and Galle, 2000).
A variety of drugs and toxins can cause hepatocellular damage by apoptosis.
For example, acute ethanol intoxication increases the number of the apoptotic
hepatocytes probably by the elevated production of active oxidants (Kockner, 2001;
Kanzler and Galle, 2000).
During hepatitis B and C, hepatocytic up regulation of Fas has been observed.
This may be the basis for fulminant hepatic failure occasionally seen in these
patients. A further example of Fas-mediated liver-cell damage, potentially leading to
acute liver failure is Wilson’s disease (Kockner, 2001).
As for viral hepatitis B, autoimmune hepatitis is marked by lymphocytic
infiltrates and apoptotic cell death with the pattern of ‘piecemeal necrosis’. Loss of
cholangiocytes with subsequent ductopenia is characteristic for the cholestasis
observed in the presumably autoimmune chronic cholestatic liver diseases, such as
primary biliary cirrhosis, primary sclerosing cholangitis and biliary atresia (Kockner,
2001; Kanzler and Galle, 2000).
As in most types of cancer, in hepatocellular carcinoma (HCC), there is a
decreased level of apoptosis seen in addition to the increased level of proliferation. It
is known that escape from the apoptosis is present in all stages of HCC development
(Kockner et.al., 2001).
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Other than the involvement of apoptosis in the liver diseases, it has also been
postulated that apoptosis of hepatocellular and biliary epithelial cells contribute to
cell death during allograft rejection (Kockner, 2001).
1.4. Bcl-2 family of regulators of apoptosis.
The Bcl-2 protein family consists of both pro- and anti-apoptotic members
from both mammalians and nematode. Also there are many homologues of the
family members that are present in different types of viruses. The founder of the
family, Bcl-2, was first identified in 1985 as the part of the most common
translocation in human B-cell lymphoma (Bakhshi et.al., 1985). In that time, this was
the first oncogene, which does not stimulate cell proliferation but yet extends the
survival of the cell. After the identification of Bcl-2 as a survival factor, many
different homologues were identified and characterized. The main homology
domains between the different members of the family are characterized as Bcl-2
Homology domains (BH), which are BH1, BH2, BH3, and BH4 domains. This
family of proteins is highly conserved throughout the evolution, since any member of
the family have more than %90 homology within different species. Almost all
members of the family have a carboxy-terminal transmembrane domain in addition
to their BH domains. The family members can be divided into 3 main sub-families
(Figure 1.1): (1) Anti-apoptotic members (Bcl-2, Bcl-xL, Bcl-w, Mcl-1, A1/Bfl-1,
and Diva), which have all four BH domains and C-terminal transmembrane domains
(as an exception Diva does not have BH3 domain); (2) pro-apoptotic members (Bax,
Bak, and Mtd/Bok) which have all BH domains except BH4 domain, and the
transmembrane domains; (3) ‘BH3-only’ pro-apoptotic members (Bad, Bid,
Bik/Biklk, Bim, Hrk, and Bnip3), which have only the BH3 domain with an
18
Figure 1.1. The subfamilies of Bcl-2 family and homology domains (BH
domains) within the family (adapted from Gross  et.al., 1999).
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additional transmembrane domain (Adams and Cory, 1998; Tsujimoto and Shimizu,
1999).
Generally, the Bcl-2 family of proteins determines the life-or-death of a cell by
controlling the releases of mitochondrial apoptogenic factors, Cytochrome c and
AIF, that activate the downstream executional phases, including the activation of the
caspases. Bcl-xL, but not Bcl-2, was also known to prevent caspase activation by
sequestering Apaf-1 (Tsujimoto and Shimizu, 1999).
Homodimerization is an important pre-requisite for some members, like Bax, in
order to function. A unique feature of this family of proteins is the hetero-
dimerization between anti-apoptotic and pro-apoptotic proteins, which is considered
to inhibit the biological activity of their partners. This heterodimerization is mediated
by the insertion of a BH3 region of a pro-apoptotic protein into a hydrophobic cleft
composed of BH1, BH2, and BH3 from an anti-apoptotic protein. Also the BH4
domain is essential for the anti-apoptotic activity, in addition to the BH1 and BH2
domains. But only the BH3 domain is sufficient for the pro-apoptotic activity (Gross
et.al., 1999).
It has been shown that Bcl-2, Bcl-xL, and Bax form ion channels in synthetic
lipid membranes. Bid, which is a ‘BH3-only’ subfamily member, was also shown to
have a channel-forming ability on synthetic lipid membranes. In addition, Bcl-2 has
an ability to prevent the channel formation function of Bax in liposomes. However, it
is still unknown whether the Bcl-2 family proteins actually form ion channels in vivo
(Tsujimoto and Shimizu, 1999).
Bax has been shown to interact with VDAC and ANT. Furthermore it was
shown that Bcl-xL closes the VDAC channel on liposomes, whereas Bax/Bak appears
to open the channel so that Cytochrome c passes through the channel. Unlike the
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Bax/Bak, BH3-only proteins such as Bid and Bik do not directly affect VDAC
activity on liposomes, suggesting that they function through pro-apoptotic family
members such as Bax and Bak or through a totally different mechanism. As
evidence, Bid was shown to induce a conformational change of Bax and Bak, as
assessed by an increased accessibility of some antibodies to Bax and Bak, which
would otherwise be non-reactive. However, it was known that Bax/Bak-induced
cytochrome c release is totally different from Bid/Bik-mediated cytochrome c release
(Tsujimoto and Shimizu, 1999).
Both of the pro- and anti-apoptotic members of the family were shown to be
transcriptionally responsive to induction via very different sets of transcription
factors (Gross et.al., 1999; Tsujimoto and Shimizu, 1999; Adams and Cory, 1998).
Pro-apoptotic members of the family are activated via a conformational change,
possibly leading to the exposure of their BH3 domains via different mechanisms.
These mechanisms include dephosphorylation (Bad), proteolytic cleavage by
caspases (Bid), oligomerization and translocation (Bax). One model on Bax and Bak
suggests that their amino terminus are concealed to keep the molecules in a closed
configuration until an activation stimulus results in a conformational change that
manifests in its release. As evidence, it was shown that the removal of the amino-
terminal 20 amino acids of Bax enabled its targeting to mitochondria in the absence
of any apoptotic stimuli. Also the amino terminal of Bid is cleaved by Caspase 8 in
Fas-mediated apoptosis in order to activate it. Bim is normally localized to the
microtubule-associated dynein motor complex via its amino-terminus and the
removal of its amino terminus makes it constitutively active. Different pro-apoptotic
members are activated as a response to different apoptotic stimuli: Bid is implicated
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in Fas-mediated apoptosis, Bax in DNA damage-induced apoptosis, and Bad in
lymphokine deprivation-induced cell death in certain cells (Gross et.al., 1999).
Bax, Bak, and Bid can integrate into the mitochondrial outer membranes,
although the other pro-apoptotic members of the family can not. For the latter ones,
their pro-apoptotic functions are restricted to their interactions with the anti-apoptotic
Bcl-2 and Bcl-xL. The evidence for this came from the studies that showed, if their
interaction with Bcl-2 or Bcl-xL is disrupted with any mutations, their pro-apoptotic
functions could no longer be seen. But the case for Bax, Bak and Bid is somewhat
different, since the mutants that can not interact with the anti-apoptotic partners can
also show their pro-apoptotic activities. Also for Bcl-2 and Bcl-xL, they exert their
anti-apoptotic activities via the interaction with the pro-apoptotic members as well as
via some other routes, since the mutations disrupt these interactions did not
completely disrupts their antiapoptotic activities (Adams and Cory, 1998).
Other than their actions on the mitochondrial membrane, Bcl-xL and Diva have
been reported to bind APAF-1 and some pro-apoptotic members (e.g. Bik) have been
shown to dissociate this complex (Tsujimoto and Shimizu, 1999).
There is increasing experimental evidence that apoptosis and the cell
proliferation are closely linked. Many proteins that can induce cell death are, in fact,
components of the cell-division cycle. Growth factors, besides triggering cell-cycle
progression, can act as survival factors. On the other hand, either cell-cycle block or
inappropriate mitogenic signals may result in apoptosis (Kanzler and Galle, 2000). In
the same manner, it is thought that the anti-apoptotic members of the Bcl-2 family
have some additional roles in the cell cycle or in resting cells.
22
1.5. Liver regeneration & Bcl-2 family.
The roles of the Bcl-2 family members were not so much well defined in the
regeneration process of the liver. In an early study at 1996, Kren et.al. showed in rats
after PH that the transcript levels of the bcl-2 and bcl-X changed with a peak at 6hr
post-hepatectomy, whereas bax had a peak at 18hr, and 72 hr post-PH. Interestingly,
they showed that other than the transcriptional activation, the mRNA stability of
these genes were increased at different levels and time points after the hepatectomy.
More surprisingly, the protein levels of Bcl-2 and Bcl-X showed no significant
changes through 96 hours, although their transcript levels were changed. But the
changes in protein level of Bax seemed to be parallel with its changes in transcript
level.
Tzung S-P et.al. (1997) showed in mice, that after 60% PH, the steady state
levels of bcl-X mRNA exhibited a cyclical pattern, with peaks at 4 hours (early G1)
and 48 to 72 hours (G1 phase of the second hepatocyte cell cycle). a1 and bcl-2
mRNA were not detected, and the levels of two mcl-1 mRNA species remained low
without significant changes. bak, bad, and bax, all showed an early decline in mRNA
levels when bcl-x transcripts increased, followed by later peaks at 12, 24, 48 to 72
hours, respectively. bcl-xL protein reached highest levels at 12 hours, consistent with
the expression of a delayed early gene.
In a recent study, Masson et.al. (2000) showed that in normal rats, just after the
2/3 PH, the transcript level of antiapoptotic bcl-2 and bcl-xL had an early increase,
whereas, the pro-apoptotic bad, bak, and bax had a delayed increase.
Kamimukai et.al.(2001) showed recently that the rats were died due to hepatic
failure after 95% PH, although they survived after 90% PH. Interestingly, they
showed  increased levels of bcl-xL expression in these surviving rats that undergo
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90% PH with decreased levels of apoptosis compared to 95% PH group. The
transfection of bcl-2 to the 95% group decreased the level of apoptosis in the livers
of this group of rats, although they still died due to the lack of insufficient
proliferation.
1.6. Importance of liver regeneration studies.
The studies on liver regeneration can be simply divided into two groups: (i) on
basic research in order to understand the cell-cycle, and proliferation control; (ii) on
basic and applied research in order to understand the response of the liver to the
decrease of the hepatic mass.
 For the first group of studies, liver regeneration after a PH is a unique real in
vivo system. Since near all hepatocytes are in G0 phase (quiescent) in normal liver,
almost all of them enter into the cell cycle, simultaneously. So any contradiction due
to the presence of cells in different stages of the cell cycle does not occur (Gang
M.H., 2001).
For the second and the largest group of studies, the important thing is to
understand the reason and the mechanism of the hepatic response to a decrease in
hepatic mass via PH or to either chemical- or a viral disease-induced hepatic failure.
These studies are important in order to understand the mechanism of molecular
physiology, and pathology of the liver, as well as to create new therapeutic
approaches to liver diseases, like cirrhosis, hepatitis, and hepatocellular carcinoma.
Recently, Yokoyama H. et.al. (2000) showed in rats that 60% PH cause a regression
of tumor although 30% cause an accelerated progression. Their results suggest that
the regression is due to the apoptosis induced during regeneration after resection.
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 Liver regeneration studies also have a high degree of importance for the liver
transplantation studies. With every liver transplant, some hepatic injury is
experienced by the donor organ. For successful engraftment to occur, the hepatic
injury must be balanced by an equal amount of hepatic regeneration. This
regeneration is required to replace liver cells lost in the graft as a consequence of any
one or more of the following hepatic injuries: hypoxia, reperfusion, ischemia, or
rejection.
Moreover, because of a variety of surgical considerations, the donor organ is
often smaller than the diseased resected native liver. As a result, the liver graft is
often too small for the recipient’s long-term metabolic needs and compensatory
hyperplasia occurs with the liver graft growing at a rate of 100 to 140 gram per day
(Kam et.al., 1987). Grafts that are adversely affected by rejection show even greater
degrees of hepatic regeneration with nodule formation, bile ductular proliferation,
and bridging scars that can stimulate cirrhotic nodules (Van Thiel et.al., 1987). Thus,
some degree of hepatic regeneration occurs with every liver transplant. The degree to
which this regeneration process is manifest, however, is often inversely related to the
degree of adversity experienced by the graft.
      1.7. Aim of Study.
During the regeneration of liver as a response to partial hepatectomy, apoptosis
occurs, as shown previously for some time points, in order to eliminate the defective
cells appeared after cellular divisions, and to make a fine-tuning of the liver size and
for tissue remodeling. Bcl-2 family of proteins, which are the most important and
critical regulators of apoptosis, should be tightly regulated during regeneration in a
time-dependent manner throughout the process. Therefore, in this study, our aim was
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to show the expressional changes of some members of Bcl-2 family (bcl-2, bcl-xL,
bcl-w, bax, bak, bid, and mtd) in transcript levels in different time groups after partial
hepatectomy in rats.
In order to test our hypothesis, we determined the relative transcript levels in
the livers of rats, which were subjected to either 40% PH, or 70% PH, or Sham
operation, by using the semi-quantitative PCR technique.
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2. MATERIALS AND METHODS
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2.1. ANIMALS
Male, 9-weeks old and 200-300 grams Sprague-Dawley rats were used. They
were housed under controlled environmental conditions (22ºC) with a 12-hour light
and 12 hour dark cycle in the animal holding facility of the Department of Molecular
Biology and Genetics at the Bilkent University, Turkey. The animals were permitted
unlimited access to food and water at all times.
2.2. STANDARD SOLUTIONS AND BUFFERS
10x MOPS: (for 1lt)
41,8 gr MOPS
16,6 ml 3 M NaAc
20 ml 0,5 M EDTA (pH=8.0)
LB MEDIUM: (for 1lt)
10 gr bacto-tryptone
5 gr yeast extract
10 gr NaCl
50 X TAE BUFFER: (for 1lt)
2 M Tris Base (242 g)
57.1 ml Glacial Acetic Acid
50 mM EDTA.
2.3. CLONINGS
Rat homologues of the three Bcl-2 family genes (bak, bid, and biklk) were
cloned. A housekeeping gene, cyclophilin, was also cloned from rat.
2.3.1. PRIMER DESIGN
As a housekeeping gene, we used cyclophilin, for which the primers were
designed by using the rat cDNA sequence with the GenBank Accession Number of
M19533.
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In the case of bid, bak, and biklk, the cDNA sequences of mouse and human
homologues were aligned by Blast (NCBI), and primers were chosen from the largest
conserved regions by preferring the mouse sequence in the points of mismatches.
The mice homologue of bid (NM_007544), bak (Y13231), and biklk (NM_007546);
and the human homologue of bid (AF042083), bak (U23765), and bik (NM_001197)
were used as sequences.
Primers were synthesized in the Beckman Oligo 1000M DNA Synthesizer
(Beckman Instruments Inc. CA, USA) at Bilkent University, Department of
Molecular Biology and Genetics (Ankara, Turkey).
The primer sequences used in clonings were listed in table 2.1.
2.3.2. TOTAL RNA ISOLATION FROM TISSUE SAMPLES
During RNA isolations, all the solutions and materials were treated with DEPC
in order to avoid RNase contamination.
The total RNAs were isolated from brain, liver, and testis with Tripure solution
(Roche-Boehringer Mannheim) by using the manufacturer’s protocol.
100 ug of tissue samples were homogenized in 1 ml of Tripure solution by
using the homogenizer. The homogenates were incubated for 5 minutes at room
temperature for complete dissociation of the nucleoprotein complexes. Then 0.2 ml
of chloroform added and shaked vigorously for 15 seconds. After incubating them at
room temperature for 15 minutes, they were centrifuged at 12 000 xg for 15 minutes
at 4ºC. Three phase were occurred after centrifugation. The colorless upper aqueous
phases were transferred to new eppendorf tubes and 1ml of isopropanol was added
on each sample. After mixing it by inverting the tubes several times, they were
incubated at room temperature for 10 minutes. Then they were centrifuged at 12 000
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bak
(536 bp)
Forward
Reverse
:5’-CCGGAATTCCAGGACACAGAGGA-3’
:5’-CCAAGCTTGCCCAACAGAACCAC-3’
bid
(316 bp)
Forward
Reverse
:5’-GGTTCGGAAGAATAGAGCCAGAT-3’
:5’-CCACTTAAGACATCACGGAGCAG-3’
biklk
(273 bp)
Forward
Reverse
:5’-GCAAGCTTCGGCGATGAGATG-3’
:5’-GAACGGATCCCCACCCAGCAG-3’
cyclophilin
(211 bp)
Forward
Reverse
:5’-GGGAAGGTGAAAGAAGGCAT-3’
:5’-GAGAGCAGAGATTACAGGGT-3’
Table 2.1. The oligonucleotide sequences used in clonings.
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 xg for 10 minutes at 4ºC and the supernatant were discarded. The pellets were
washed with 1 ml of 75% ethanol by vortexing, and then centrifuged at 7 500 xg for
5 minutes at 4ºC. The supernatants were discarded and the pellets were air-dried on
bench for about 10 minutes. The RNA pellets were resuspended in appropriate
volume of the DEPC-treated water.
2.3.3. DETERMINATION OF RNA CONCENTRATION BY
SPECTROPHOTOMETRY
1 ul of each samples were diluted 1:1000 with DEPC-treated ddH2O. Then the
O.D. measurements were done for 260 and 280 nm wavelengths with the
spectrophotometer (Beckman). The concentration of the RNA samples were
calculated with the formula:
[RNA] = O.D.260 X dilution factor (1000) X 40
And the O.D.260/ O.D.280 ratios were calculated in order to understand if there is a
phenol, protein or DNA contamination in our RNA samples.  The ratio values
between 1.6-2.0 were the expected results.
2.3.4. DENATURING AGAROSE GEL ELECTROPHORESIS
2.3.4.1. Preparation of the gel (1.2%)
1.2 gr of agarose was dissolved in 87 ml of DEPC-treated ddH2O in a
microwave. When it is cooled to ~50ºC, 10 ml of 10X MOPS and 3 ml of 40%
formaldehyde were added dropwise, while stirring with a magnetic stirrer. Just
before pouring the gel, 5 ul of ethidium bromide(10mg/ml) was added.
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2.3.4.2. Preparation of the samples for loading
For 5.5 ul (5 ug to 10 ug) of RNA sample, they were mixed with 1 ul of 10X
MOPS, 3.5 ul of 40% formaldehyde and 10 ul of deionized formamide. Then the
samples were denatured by incubating for 15 minutes at 65ºC. Samples were then
spinned down briefly and kept on ice until loading. They were loaded on the
polymerized casted gel, which was previously placed into the electrophoresis-tank
filled with 1X MOPS. Then the samples were run with 60 V for 4 hours. After the
completion of the electrophoretic separation of the samples, the gels were visualized
under the U.V. and the images were captured by the transilluminator apparatus with
the Multi-Analyst software.
The integrities of the RNA samples were determined by the integrity of the
ribosomal RNA bands (18S and 28S rRNA).
2.3.5. RT-PCR
The cDNA samples were synthesized from the total RNA samples with the
RevertAid First Strand cDNA Synthesis Kit (MBI Fermentas) by using the
manufacturer’s protocol.
5 ug of RNA samples were mixed with 1 ul of oligo (dT)18 primer and ddH2O
in a total volume of 12 ul. They were incubated at 70ºC for 5 minutes and then
chilled on ice. Then 4 ul of 5x reaction buffer, 1 ul of Ribonuclease inhibitor and 2 ul
of 10 mM dNTP mix  were added and incubated at 37ºC for 5 minutes. Finally, 1 ul
of RevertAid M-MuLV reverse transcriptase were added and incubated at 42 ºC for
60 minutes. The reactions were stopped by heating at 70ºC for 10 minutes and put
into the ice.
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2.3.6. Polymerase Chain Reaction (PCR)
Polymerase chain reaction (PCR), a rapid procedure for in vitro enzymatic
amplification of a specific segment of DNA (Mullis and Faloona 1987), was
performed to amplify the partial coding sequences of bak, bid, biklk, and cyclophilin.
PCR reactions were performed in 0.2 ml ThermowellTM tubes (Corning Costar Corp.)
using the GeneAmp PCR system 9600 (Perkin Elmer).
PCR reactions were carried out in a reaction volume of 25 ul containing 1 ul of
cDNA template , 2.5 ul 10x PCR buffer (MBI Fermentas), 1.5 mM MgCl2 (MBI
Fermentas), 0.2 mM of each dNTP (MBI Fermentas), 50 pmole of each primer and 1
unit Taq DNA polymerase (MBI Fermentas).
The reaction was preheated to 94oC for 5 minutes and then subjected to 35
cycles of denaturation (30 seconds at 95oC), annealing (30 seconds at 52oC for bid,
or 55 oC for bak, or 58 oC for biklk), and elongation (30 seconds at 72oC).  At the end
of the 35 cycles a final extension at 72oC for 10 minutes was also applied.  15 ul of
the PCR products were assessed by agarose gel electrophoresis and Ethidium
Bromide staining.
2.3.7. LIGATION
For the cloning purposes, the pGEM-T and pGEM-T Easy vector systems
(Promega) was used (Figure 2.1.).
Approximately 200 ng of the PCR product is mixed with 5 ul of 2x rapid
ligation buffer, 1 ul (50 ng) of pGEM-T or PGEM-T Easy vector and 1 ul of T4
DNA Ligase in a total volume of 10 ul. Then they were incubated at 16ºC for 20
hours.
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Figure 2.1. The maps of the pGEM-T and pGEM-T Easy vectors
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2.3.8. CaCl2-TRANSFORMATION of E.Coli
DH5-α strain of E.Coli was used in clonings.
1 ml of DH5-α culture (108 cells/ml) were taken into an eppendorf tube and
spinned down at 13 000x rpm for 1 minutes. After discarding the supernatant, the
pellets were resuspended in 0.5 ml ice-cold CaCl2. Following the incubation on ice
for 30 minutes, they were centrifuged at 13 000x rpm for 45 seconds. After
discarding the supernatant, the pellets were gently resuspended in 100 ul of ice-cold
CaCl2. All the ligation products at section 2.7 were added and then the mixtures were
incubated on ice for 30 minutes. Then the heat-shock was done by incubating them at
42ºC for 90 seconds, and then immediately chilled and incubated on ice for 2
minutes. After this heat shock, 1 ml of LB medium was added and incubated at 37ºC
for 1 hour. Then they were inoculated and spreaded on solid LB-agar plates that
contained ampicillin, IPTG and X-Gal. After incubating the plates at 37ºC for 16-18
hours the colonies appeared as either blue or white in color.
2.3.9. MINIPREP (Small-Scale Preparations of Plasmid DNA)
The bacteria from the white colonies were inoculated on LB medium and
grown at 37ºC for 18 hours. Then 1.5 ml of culture were taken to eppendorf tubes
and spinned down at 13 000x rpm for 1 minutes. After discarding the supernatants,
the pellets were dissolved by vortexing in  0.1 ml of solution 1 (50 mM Glucose; 25
mM Tris.Cl –pH=8.0-; and 10 mM EDTA-pH=8.0). After incubating at room
temperature for 5 minutes, 0.2 ml of freshly prepared solution 2 (0.2 N NaOH; 1%
SDS) was added and mixed by inversion. After the tubes were incubated on ice for 5
minutes, 0.15 ml of solution 3 (for 100 ml: 60 ml 5M potassium acetate, 11.5 ml
glacial acetic acid, 28.5 ml H2O) was added and vortexed. Then they were put into
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ice for further 5 minutes, and centrifuged at 13 000x rpm for 15 minutes at 4ºC. The
supernatants were transferred to new eppendorf tubes carefully. Onto the
supernatants, 1 ml of absolute ethanol was added and mixed. They were incubated at
-70ºC for 30 minutes and then spinned down at 13 000x rpm for 15 minutes at 4ºC.
After discarding the supernatants, the pellets were air-dried, and then dissolved in
appropriate amount of ddH2O.
2.3.10. RESTRICTION ENZYME DIGESTION OF DNA
Depending on the amount of DNA (1-5 ug), restriction enzyme digests of DNA
was carried out in a total volume of 20-50 ul with 10-50 units of restriction enzyme,
Appropriate buffers and incubation conditions were used for each digest as
recommended by the manufacturer. In order to check the presence of the inserts, they
were excised out from the vector by EcoRI digestion.
2.3.11. MIDIPREP (Large-Scale Preparations of Plasmid DNA)
For the midiprep, the Nucleobond AX-100 kit (Macherey-Nagel) was used.
For this purpose, transformed bacteria were inoculated into 30 ml of LB culture
with 50 ug/ml ampicillin and were incubated at 37ºC for overnight.
Then the bacterial cultures were spinned down by centrifugation at 5 000x g
for 10 minutes at 4ºC. After discarding the supernatant, the pellets were carefully
resuspended in 4 ml of buffer S1. 4 ml of buffer S2 were put and mixed by inversion.
The suspensions were incubated at room temperature for 5 minutes. Then 4 ml of
buffer S3 was added, and immediately mixed by inversion. After incubating on ice
for 5 minutes, they were centrifuged at 12 000x g for 30  minutes at 4ºC. After the
equilibration of the cartridges with 2.5 ml of buffer N2, the supernatants from the
previous step were loaded on cartridges. The cartridges were washed twice with 5 ml
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of buffer N3. Then the plasmid DNAs were eluted from the cartridges with 5 ml of
buffer N5. Purified plasmid DNA samples were then precipitated with 4 ml of
isopropanol and were centrifugated at 15 000x g for 30 minutes at 4ºC.  After
discarding the supernatant, the pellets were washed with 70% ethanol and spinned
down at 15 000x g for 10 minutes at 4ºC. Finally, the supernatant is discarded and
the pellets were air-dried and dissolved in appropriate volume of ddH2O. Then their
concentrations were measured by using spectrophotometer, and checked with
agarose gel electrophoresis.
2.4. PARTIAL HEPATECTOMY AND DISSECTION
In this study, the 9-week old male Sprague-Dawley rats were used.
2.4.1. 40 % PARTIAL HEPATECTOMY
The rats were anesthetized with Ketalar (Parke-Davis) and immobilized on the
bench. After the sterilization with 70% ethanol, the skins were cut with a scissor.
After removing the subcutaneous structures, the peritoneal membranes were cut
carefully throughout the midline resulting in the opening of the abdomen. The
intestines were carefully taken out into a saran-wrap and by using serum physiologic
(0.9% NaCl) drying of the intestines was avoided.
Then the ligaments of the liver that connect the organ to the diaphragm, and the
lobes to each other were cut. The middle lobe, which accounts for the 40% of the
total liver mass, was cut after the tying of the branch of vena cava inferior that enters
to this lobe with silk. The color of this lobe immediately became dark after tying,
which was due to the cutting of blood supply to this lobe. Then the lobe was washed
in DMEM medium and then quickly frozen in liquid nitrogen.
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After removing the lobe, the abdominal cavity of the animal was cleaned
carefully. The intestines were placed to their original locations. Then the peritonea
and the skin were closed separately by using propilen. After the completion of the
surgery, the animals were placed under a lamp to increase its body temperature and
then put into cages (one animal per cage) with continuous supply of food and water.
The resected and frozen lobes were weighted and the mass values were
recorded.
2.4.2. 70 % PARTIAL HEPATECTOMY
In 70% PH, in addition to middle lobe, the front lobe, which accounts for the
30% of the total liver mass, was also removed after tying the branch of the vena cava
inferior that enters into the front lobe with silk. The same procedures were used as in
40% PH, after the removal of the frontal lobe(Figure 2.2.).
2.4.3.  SHAM OPERATION
For the Sham group of animals, all the surgical operations done were same as
PH, but the livers were not tied up and resected.
2.4.4. EXPERIMENTAL GROUPS
Animals were sacrificed by the dislocation of the neck according to their time
groups. After the neck dislocation, the skin and peritoneum of the animals were
quickly opened, and the liver tissue was cut from the vena cava inferior, carefully,
washed in DMEM medium, and immediately frozen in liquid nitrogen. The dissected
and frozen liver tissues were weighted and recorded for further calculations.
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Figure 2.2. The liver resection surgery for partial hepatectomy.  70%
resection was shown as representation.
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For the 40% and 70% PH groups, the time of the resection of the middle lobe is
considered as 0 hr. For each time group, 2 animals were used for the 40% and 70%
PH groups. For the Sham group, the time when the intestines were put into the saran-
wrap was considered as 0 hr, and one animal was used for each time group. The time
groups used in this study were 0,5 hr, 1 hr, 2 hr, 4 hr, 8 hr, 12 hr, 18 hr, 24 hr, 36 hr,
2 days, 3 days, 5 days, 7 days, 10 days, and 14 days.
2.4.5. MASS GRAPHS
Normally, the total weights of livers were not same between different animals.
So that, in order to normalize the values, we defined a term, ‘mass unit’. For each
animal 1 mass unit was calculated by dividing the weight of its resected liver tissue
by 40 or 70 for 40% and 70% PH groups, respectively. After obtaining the mass unit
conversion values, the weight of the regenerated liver tissues were converted to mass
units by dividing their actual weights by the obtained conversion values for each
animal.
2.5. TOTAL RNA ISOLATION
The RNA were isolated from all the liver samples with the Tripure solution
(Roche-Boehringer Mannheim) by using the manufacturer’s protocol as explained in
detail at section 2.3.2. The integrity of the isolated RNA samples was determined by
denaturing- (formaldheyde-) agarose gel electrophoresis as explained in section
2.3.4. Then the concentrations of the RNA samples were determined by
spectrophotometric measurements, as in section 2.3.3.
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2.6. RT-PCR
The cDNA samples were synthesized from the total RNA samples with the
RevertAid First Strand cDNA Synthesis Kit (MBI Fermentas) by using the
manufacturer’s protocol as explained in Material and Methods 2.3.5.
2.7. SEMI-QUANTITATIVE PCR
Semi-quantitative PCR is a suitable method for comparing the relative amount
of the used templates between different samples. Normally, the PCR reaction does
not have a linear graph for product amount versus cycle number. In algebraic terms,
it is the graph of the combination of two functions. This is due to the saturation of the
polymerase chain reaction (PCR). In order to have a dependable comparison, the
cycle number, in which the PCR reaction is not saturated, should be determined for
each of the genes. This was done by performing the PCR reaction for different cycles
for each gene and drawing a graph from the intensity of the DNA bands assessed by
agarose gel electrophoresis.
2.7.1. PRIMER DESIGN
We have designed primers for bcl-2, bcl-xL , bax, mtd, and bcl-w by using the
cDNA sequences of rat homologues of these genes, which are available at the
GenBank database. The GenBank Accession numbers of rat homologues of bcl-2 is
NM_016993; of bcl-xL is U34963, of bax is S76511, of mtd is NM_017312, and of
bcl-w is AF096291.
For cyclophilin, bak, and bid the primer pairs in Table 2.1. were also used in
semi-quantitative PCRs. All the oligonucleotide sequences used in semi-quantitative
PCR reactions were listed in Table 2.2.
41
cyclophilin
(211 bp)
Forward
Reverse
:5’-GGGAAGGTGAAAGAAGGCAT-3’
:5’-GAGAGCAGAGATTACAGGGT-3’
bcl-2
(584 bp)
Forward
Reverse
: 5’-CCTGGCATCTTCTCCTTC-3’
:5’-TGCTGACCTCACTTGTGG-3’
bcl-xL
(346 bp)
Forward
Reverse
:5’-TCAATGGCAACCCTTCCTGG-3’
:5’-ATCCGACTCACCAATACCTG-3’
bax
(272 bp)
Forward
Reverse
:5’-ACGCATCCACCAAGAAGC-3’
:5’-GAAGTCCAGAGTCCAGCC-3’
bak
(536 bp)
Forward
Reverse
:5’-CCGGAATTCCAGGACACAGAGGA-3’
:5’-CCAAGCTTGCCCAACAGAACCAC-3’
bid
(316 bp)
Forward
Reverse
:5’-GGTTCGGAAGAATAGAGCCAGAT-3’
:5’-CCACTTAAGACATCACGGAGCAG-3’
mtd
(400 bp)
Forward
Reverse
:5’-GTGGATCCGCGGCGCTCTTCTGTCTTC-3’
:5’-CAAGCTTCAGCCACCGAGTACAGGGA-3’
bcl-w
(326 bp)
Forward
Reverse
:5’-GCGGATCCATAAGCTGAGGCAGAA-3’
:5’-GGAAGCTTTGCACTTGTCCCACCA-3’
Table 2.2.  Oligonucleotide sequences used in semi-quantitative PCR reactions.
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2.7.2. SEMI-QUANTITATIVE PCR OPTIMIZATION
Semi-quantitative PCR optimizations were done by preparing a large volume
of the reaction for each gene and then by dividing this to several individual PCR
tubes, in order to prevent the errors that may have arise from pipetting. At the end of
the each cycle, one tube was taken and the final extension of this reaction were
performed by incubating at 72ºC for 10 minutes. Then the reaction was stopped by
putting the tube on ice.
After the completion of all cycles in the same manner, 20 ul of the 25 ul of
PCR products were assessed by agarose gel electrophoresis and ethidium bromide
staining. The results were analyzed by the Multi-Analyst software and the graphs
were drawn. The optimum cycle numbers for semi-quantitative PCR reactions were
determined from the graphs. All the optimizations were done by using the cDNA
template of normal rat liver.
2.7.3. SEMI-QUANTITATIVE PCR
For all the experimental samples, the semi-quantitative PCR reactions were
done from the same master mix, simultaneously. The PCR was done first by using
the robotics (Beckman Biomek 2000 Laboratory Automation Workstation) and then
repeated once more by hand. In all reactions the negative control group was done by
using ddH2O instead of cDNA.
The quantitated values for the Bcl-2 family members were normalized with the
quantitated values for the cyclophilin for each sample, separately. And the resulting
graphs were drawn by these normalized values.
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3. RESULTS
44
3.1.  INTRODUCTION
Liver regenerates itself by increasing its mass to compensate the loss of its
functional capacity. This decrease in its capacity can occur after hepatic failure by
chemicals, viral infection, or by PH. However, uncontrolled proliferation can also
cause some problems that may result in the loss of homeostasis. So that the fine-
tuning of the liver mass is quite important during regeneration in order to maintain
the homeostasis. Apoptosis is the main tool for any organism for such a fine-tuning,
since it causes elimination of the cells in an organism without disrupting the integrity
of the tissue.
Due to the accumulation of knowledge on apoptosis, the involvement of this
cellular death mechanism in the process of liver regeneration has become a
promising research area. It has been shown that, mitochondria have a central role in
the regulation of apoptosis by controlling the release of apoptotic factors. Among
these factors, Cytochrome c, which causes the activation of caspases cascade, is one
of the most important one. In this regulation, Bcl-2 family of proteins has been
shown to have many critical roles. The anti-apoptotic subfamily members are
thought to prevent the apoptosis by at least blocking the release of these factors from
mitochondria. In contrast, pro-apoptotic subfamily members cause directly or
indirectly the activation of the apoptotic machinery.
In the regulation of these bcl-2 family member genes, the transcriptional
control has been shown to be important as well as the post-translational control.
Therefore, in this study, our aim was to show the expressional changes of some
members of the bcl-2 family (bcl-2, bcl-xL, bcl-w, bax, bak, bid, biklk, and mtd) at the
mRNA levels up to 14 days after partial hepatectomy in rats. For this purpose, we
used the semi-quantitative PCR technique to determine the relative transcript levels
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in the livers of different time groups of rats that were subjected to either 40% PH,
70% PH, or Sham operation.
3.2.  CLONINGS
In the beginning of this study, the rat homologues of bak, bid, and biklk were
not known. Therefore, first we aimed to identify and clone the rat homologues of
these genes. The primers were designed as explained in Materials and Methods.
Brain, liver, and testes were chosen for the identification of these homologues, since
these tissues expressed these genes at high levels, in mice. After the isolation of
RNA from these three tissues, their integrities were checked by denaturing agarose
gel electrophoresis (Figure 3.1.). Then the cDNAs were synthesized by RT-PCR
from these RNA samples. The corresponding cDNA fragments were amplified by
PCR (Figure 3.2.) and cloned into either pGEM-T or pGEM-T Easy vector. After a
series of insert check with restriction enzyme digestions, the cloned fragments were
sequenced and aligned with the mice homologues of the corresponding genes (Figure
3.3.).
Also the cyclophilin gene, which is a housekeeping gene, was cloned in order
to use in further experiments. The amplified fragment with PCR (Figure 3.2.a)
cloned into the pGEM-T Easy vector. After checking the presence of the insert
within the vector, it was sequenced and aligned with the sequence in the GenBank
database.
The sequencing were carried out on an ABI Prism 310 Sequencer in
Department of Molecular Biology and Genetics at Bilkent University.
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Figure 3.1. Integrity check of RNA samples on denaturing agarose gel. The
isolated RNA samples from Brain, Liver and Testes were electrophoresed in 1.2%
denaturing agarose gel. The integrity of the 28S and 18S rRNA bands indicates the
integrity of the isolated total RNA. Control is the RNA sample from HepG2 cells.
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Figure 3.2. PCR production of the gene fragments. cyclophilin was amplified
from liver cDNA, whereas brain cDNA was used for bak and bid and testes cDNA
was used for biklk. The sizes of the amplified fragments were as expected. M is the
100bp (+) DNA Ladder (MBI Fermentas) for d, and 100bp DNA Ladder (MBI
Fermentas) for a, b, and c.
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Figure 3.3. Alignment of the sequencing results with the sequence of the
corresponding gene’s mice homologue. The sequence alignment of bid/pGEM-T
was given as a representation. FRW SEQ was the result obtained by sequencing with
M13 forward primer and REW SEQ was the one with M13 reverse primer. The lines
with ‘GENBANK’ is the sequence of the mice homologue of the bid in GenBank
database.
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Actually, by the time we cloned the rat homologues of bak, bid, and biklk, some
other researchers also identified, cloned and sequenced them. So we checked if the
sequence we obtained were similar to their sequences entered into the GenBank with
the accession numbers of AF259504 for bak, AF136282 for bid, and AF372501 for
biklk. According to the alignment of our partial cDNA sequences with their complete
sequences, we observed that they were completely same.
3.3.  RESULTS OF PARTIAL HEPATECTOMY
We have performed our studies in male rats due to their hormonal stability. For
40% and 70% partial hepatectomy, two animals were used for each time group,
whereas one animal was used for Sham groups. We chose a time spectrum that
contains different time points from 0.5 hours to 14 days (0.5 hr, 1 hr, 2 hr, 4 hr, 8 hr,
12 hr, 18 hr, 24 hr, 36 hr, 2 days, 3 days, 5 days, 7 days, 10 days, and 14 days). Since
the regeneration of liver after 70% PH is completed in 10-14 days after hepatectomy
in rats, unlike other studies on liver regeneration, we extended time groups till the
completion of this process. Previous studies on the correlation of liver regeneration
and Bcl-2 family of genes have been done for only 2-3 day after PH, and our study
was the first one that include such long experimental groups.
3.3.1. MASS CURVES
All the resected and regenerated liver tissues were weighted after the removal.
From the obtained mass values, mass graphs were drawn by normalizing the values
by assuming the resected lobes as 40 or 70 mass unit (m.u) for 40% and 70% groups,
respectively (Figure 3.4.).
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As seen in Figure 3.4, the liver masses were increased by time in both 40% and
70% groups, which indicates the liver regeneration. As Fausto et.al. (1990)
mentioned before, the increase in the mass is not due to the hypertrophy, but due to
the cellular divisions. They showed the presence of proliferation in the increase of
size, by determining the [3H]-thymidine incorporation into the genomic DNA of cells
in regenerating liver tissues.
According to the mass curve we obtained for 40% PH group (Figure 3.4a.), the
values for the time groups through 12 hr to 14 days deviate too much between two
animals in the same group. The expected times of first and second cellular divisions
(18 hr and 36 hr, respectively) also fall into this time period. But it was clear from
the graph that, these animals’ livers reach to the expected level of normal liver size at
7 days post–hepatectomy. But interestingly, the liver mass continues to increase after
the complete restoration of the mass at 7 days.
For the 70% PH group of animals (Figure 3.4.b.), the complete restoration of
liver mass was completed more or less at 14 days post-hepatectomy. The apparent
decrease in the liver mass during regeneration was seen at 24 hr, 48 hr, and 3 days.
The first two of them were the time groups just after the expected first and second
cellular division times, as mentioned above.
According to a previous study (Sakamato T. et.al., 1999), apoptosis occurs at 3
days post-hepatectomy in rats subjected to 70% PH. And we observed a decrease in
total liver mass at 3-days group of animals, which may be due to this observed
apoptosis.
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Figure 3.4. Mass graphs for 40% and 70% PH groups. For each animal 1 mass
unit was calculated by dividing the weight of its resected liver tissue by 40 or 70 for
40% and 70% PH groups, respectively. Then, the weight of the regenerated liver
tissue was converted to mass unit by dividing it by the obtained value for this animal
above. a) is the time dependent graph for 40% PH group, whereas, b) is the one for
70% PH group.
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3.3.2. RNA ISOLATION and RT
To relatively quantitate the mRNA expression of bcl-2 family of genes, first
total RNA of all groups (40%, 70%, and Sham) were isolated. The integrity of the
RNA samples were checked in denaturing agarose gels (Figure 3.5). All the RNAs
were intact and pure. Their concentrations were measured by spectrophotometer and
cDNAs were synthesized by RT.
3.3.3. SEMI-QUANTITATIVE PCR
3.3.3.1. SEMI-QUANTITATIVE PCR OPTIMIZATIONS.
In order to perform semi-quantitative PCR reactions, we first optimized the
conditions -annealing temperatures and cycle numbers- as explained in Materials and
Methods for cyclophilin, bax, bcl-2, bcl-xL, bak, bid, bcl-w, and mtd by using cDNA
of normal rat liver (Figure 3.6.)
The optimized values for the semi-quantitative PCR s were listed in table3.1.
53
Figure 3.5. The integrity check of RNA samples on denaturing agarose gel.
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Figure 3.6.  Semi-quantitative PCR optimizations. The optimizations of the semi-
quantitative PCRs were done as explained in Materials and Methods. b, d, f, h, j, l, n,
and p are the results of these optimization experiment on 2% agarose gel. a, c, e, g, i,
k, m, and o are the graphs drawn with the values obtained by quantitating the
corresponding bands on gels by MultiAnalyst software. The cycle numbers that will
be used for semi-quantitative PCRs were written in bold and underlined on the gel
photos.
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Annealing
temperature
Cycle number Primer amounts
(pmole)
cyclophilin 55ºC 18 10+10
bcl-2 55ºC 33 20+20
bcl-xl 52ºC 37 40+40
bax 60ºC 28 30+30
bak 55ºC 29 20+20
bid 52ºC 29 20+20
bcl-w 55ºC 31 20+20
mtd 55ºC 30 20+20
Table 3.1. The optimized conditions for the semi-quantitative PCRs.
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3.3.3.2. SEMI-QUANTITATIVE PCR
By using the optimized semi-quantitative PCR conditions, the transcript levels
of cyclophilin, bcl-2, bcl-xL, bax, bak, bid, bcl-w, and mtd were determined in 40%
(data not shown), 70% (Figure 3.7) and Sham (Figure 3.8) groups.
The intensities of all the bands were quantitated by MultiAnalyst software. The
quantitated values for bax, bak, bid, mtd, bcl-w, bcl-2, and bcl-xL for each sample
were normalized with its quantitated cyclophilin values, separately. Then all the
normalized values were converted to the folds of normal liver values by assuming the
normal liver expression as 100. By the calculated values, the graphs (relative
transcript level vs. time) were drawn for each gene, separately.
Our results for the 40% PH group deviate too much that we cannot have a
meaningful average for them. (Figure 3.9.)
But we obtained an interesting in bcl-2 PCR for 40% PH groups (Figure 3.9.g).
Although we obtained a single bcl-2 band in normal liver and in all time groups of
Sham and 70% PH, we observed two extra bands in most of the samples of 40% PH
groups. These two extra bands have sizes of approximately 350 and 750 bp. These
two extra bands have always seen together in the same lane. And they were present
in one samples of 0.5 hr, 2 hr, 4 hr and 24 hr; and in both samples of 1 hr, 36 hr, 2
days, 3 days, 5 days, 7 days, 10 days, and 14 days. But their intensities changed in
different time groups, and animals in a time group.
The results for 70% PH and Sham groups were also obtained as explained
above. The graphs for them were drawn together, in order to compare the
expressional changes of both groups (Figure 3.10).
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Figure 3.7. The semi-quantitative PCR results for the 70% PH group. The PCR
products are electrophoresed in 2% agarose gel and visualized under U.V. (-) is the
negative control, and M is the 100bp DNA ladder (MBI Fermentas).
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Figure 3.8. The semi-quantitative PCR results for the Sham group. The PCR
products are electrophoresed in 2% agarose gel and visualized under uv. (-) is the
negative control, and M is the 100bp DNA ladder (MBI Fermentas).
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Figure 3.9. Results of semi-quantitative PCR for 40% PH groups. In a, b, c, d, e,
and f, the graphs were drawn with the calculated values as explained. The error bars
were put in order to show the deviations in the results. In g, the semi-quantitative
PCR result for bcl-2 was given. The two extra bands were seen in most of the groups,
but not in normal liver  (NL) sample. M is the 100bp DNA Ladder (MBI Fermentas).
61
Figure 3.10. Relative transcript level vs. time graphs. The graphs were drawn by
the values obtained as explained in the text. For each graph, the relative transcript
level in 70% PH and Sham group was given side-by side for each time group. 0 is the
transcript level of Normal Liver for both 70% PH and Sham groups.
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In our 70% PH groups, we observed that the transcript level of bak decreased
to half level of normal liver by two hours after hepatectomy. Although its expression
reached to the normal liver levels at 8 hr and 18 hr, it decreased to the half value in
following groups, 12 hr and 24 hr, respectively. By 36 hours, the amount of bak
transcripts started to increase with a peak at 3 day. Then, the expression level again
decreased to the level of expression in normal liver (Figure 3.10a).
30 minutes just after the 70% hepatectomy, the bax expression decreased to the
half of the normal liver expression levels. During the 10-day period, it remained
approximately at this level with small levels of decreases and increases. But then, at
14 days groups, it reached to the expression level of normal liver (Figure 3.10b).
After the resection of the 70% of the livers, the transcript levels of bid started
to decrease, and 4 hours after hepatectomy, it was only 20% to that of normal liver
expression. After that point, it makes peaks at 18 hour and 3 days groups, and by 14
days, it reached to the levels of normal liver expression (Figure 3.10c).
mRNA levels of mtd were at the half level of normal liver expression from 30
minutes to 3 days. At 3 days post-hepatectomy, it made a peak and reached to the
level of normal liver expression levels. Then, it decreased to the half level, again, and
stayed at this level in all our following time groups (Figure 3.10d).
bcl-2 expression levels did not decrease below the normal liver levels. It made
peaks at 8 hr, 24 hr, 3 day, and 7 day groups. Always the value of peaks increased in
later groups compared to previous peaks. The level of expression increased to two-
fold of normal liver level at 36 hours, whereas it remained at 3-fold after 7 days post-
hepatectomy (Figure 3.10e).
Although 8 hours after resection, the level of bcl-xL transcripts increased, it
decreased to half value of normal liver levels at 12-hour groups. After staying at this
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level for about one day, then it further decreased to the 20% of the normal liver
levels. At the end of the second day after hepatectomy, it reached to the normal
levels (Figure 3.10f).
Throughout the 5 day after PH, the expression level of bcl-w remained between
the 20% and 50 % of the normal liver values. At 7day, it increased to the normal
liver values, and by the completion of 14 days, it became two-fold of normal liver
expression levels (Figure 3.10g).
Sham operations were done in order to determine the effects of surgery on liver
or on the liver-specific expression of the genes under investigation. This is important
in order to be sure that the expressional changes seen in the PH groups are due to the
regeneration process of the liver. According to our results with the sham groups,
surgery alone has changed the expression of these genes (Figure 3.8 and Figure
3.10). In order to have a more definitive figure in determining the expressional
changes of these genes due to the hepatic regeneration, we can assume that the events
occurred in the livers of 70% PH group of animals are the combination of the events
occurred in the livers of sham group of corresponding animals and liver regeneration.
With this assumption, if we subtract the transcript levels in sham groups from the
transcript levels in the corresponding 70% PH groups, the obtained value will be the
expressional change caused by the regeneration of the liver. After calculating the
values with this formula for all time groups, separately, the time- dependent graphs
were drawn for both pro-apoptotic bak, bax, bid, and mtd (Figure 3.11a), and anti-
apoptotic bcl-2, bcl-xL, and bcl-w (Figure 3.11b).
According to Figure 3.11, it is clear that regeneration caused the suppression of
the transcripts of almost all the genes that we studied in most of the time points. The
levels of the transcripts that were highly different in 70% groups than the sham
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Figure 3.11. Graphs of time vs. liver regeneration induced changes in relative
transcript levels. The graphs were drawn by the values obtained as explained in the
text. a) Graph for pro-apoptotic members of bcl-2 family, b) Graph for anti-apoptotic
members of bcl-2 family.
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groups were from bak and bcl-2. The expressions of pro-apoptotic genes were
suppressed by regeneration process until the 3 days group. Importantly, 3-day group
was the one, we expect to see apoptosis as published by Sakamato et.al. (1999). At
this time group, the regeneration-induced expression levels of bak and mtd were
increased. However, at 3-day groups, the expressions of the anti-apoptotic bcl-2 and
bcl-xL were also increased by hepatic regeneration at the mRNA levels.
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4. DISCUSSION
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4.1.DISCUSSION
After the first mention of liver regeneration by Prometheus, several studies
accumulated a large set of information about this process. It is clear that during
evolution of the higher eukaryotes, liver gains such a regenerative capacity.
 In the mechanism of evolution during the passage from unicellular to
multicellular organisms, different sets of cells in the multicellular organisms were
specialized for separate and specific functions. And in the evolution of higher
eukaryotes, different organ systems were developed for specific functions, essential
for the survival of the organism.
Within these organ systems, liver is one of the very critical organ. It has many
major metabolic functions of the body beside its detoxification, vascular, digestive,
and endocrine functions. It is an important advantage for the organisms to gain such
a well-regulated capacity of liver regeneration, since hepatic failure, which occurs
due to some chemicals, viral illnesses, or some other pathological reasons can be
compensated in an individual by this regeneration capacity. In most of the cases, the
result would be lethal, if liver cannot be regenerated after such a hepatic failure.
During liver regeneration, liver responds not only by cellular proliferation but
also by apoptosis. It is now clear that the major functions of this programmed cell
death are the elimination of the defective cells that are appeared during the rapid
cellular division cycles, fine-tuning of liver size, and hepatic tissue modeling. So the
hepatic regeneration process can be seen as an event of two opposing mechanisms:
cellular proliferation and cellular death (Fan  et.al., 1998; Kren et.al. 1997).
Apoptosis, as a mechanism of cellular death, is very important for the
maintaining of the homeostasis in the body, and for the tissue modeling during
organogenesis. In contrast to necrosis, which is the non-programmed and sudden
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cellular death, apoptosis does not cause any inflammation in the body. The regulation
of apoptosis within a cell is very critical. Mitochondria are placed at the center of the
regulation of the apoptotic mechanisms. It contains many factors that can activate the
apoptotic degradation machinery. Cytochrome c is the most important one of these
apoptotic factors, which is responsible for the activation of the ‘caspase cascade’.
Since the activation of the caspase cascade can be initiated by the release of
Cytochrome c, controlling the release of Cytochrome c is the major concern of this
regulation mechanism.
The Bcl-2 family of proteins are involved in the regulation of the release of
apoptotic factors from the mitochondria. The family has many members; some of
them are anti-apoptotic and the others are pro-apoptotic. The anti-apoptotic Bcl-2
family members are accepted to prevent the release of these apoptotic factors from
the mitochondria, whereas the pro-apoptotic members facilitate the release of them.
These regulatory proteins are also regulated with very different mechanisms,
including post-translational (phosphorylation, dephosphorylation, dimerization,
translocation, cleavage, etc.), translational, and transcriptional controls. For all of the
members of this family, it has been shown that the transcriptional activation or
suppression is critical (Tsujimoto and Shimizu, 2000; Gross A, 1999).
Since the programmed cell death is a major component of the hepatic
regeneration mechanism, and the Bcl-2 family members are the main regulators of
this cellular death mechanism, we concentrated on the regulation of these genes
during the regeneration process of liver induced by partial hepatectomy. Therefore,
in this study, our goal was to examine the expressional changes of the bcl-2 family of
genes in transcript levels at different time points after PH in rats.
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In order to accomplish our goal, we decided to determine the expression pattern
of bcl-2, bcl-xL, bax, bid, bak, mtd, and bcl-w during liver regeneration by using
semi-quantitative PCR. When we started this project, the sequences of bak, bid, and
biklk were not known for rat. Therefore, first, we decided to identify rat homologues
of these genes. We have cloned these genes, but, unfortunately, other investigators
were able to submit their sequences to GenBank before us. Our and their sequences
were same.
Then the rats were undergone to either 40 %, or 70% partial hepatectomy, or
Sham operations. According to their mass graphs for both PH groups, it was certain
that the remaining liver tissues regenerated and reached to the size of the normal
liver after 7days, and 14 days in 40% and 70% PH groups, respectively. However,
for the 40% PH, the mass values of two animals in the same groups do not correlate
in none of the time points after 12 hr post-hepatectomy. The reason for this
discrepancy may be the fact that a 40% resection of liver may not elicit a
regenerative response completely. For example, it was thought that after
hepatectomy, the cellular divisions do not start simultaneously. Simply, 40%
resection does not result in well-orchestrated regeneration of remaining liver in all
animals. Due to this reason, most of the liver regeneration studies used 70% PH, but
not 40% PH.
In 70% PH group, it was seen that the complete restoration of liver mass could
be maintained more or less at 14 days post-hepatectomy. The apparent decreases in
the liver mass during regeneration were seen at 24 hr, 48 hr, and 3 days post-
hepatectomy. The first two of them were the time groups just after the expected first
and second cellular division periods. It can be speculated that, these decreases in
mass can be due to apoptosis, which is responsible for the elimination of cells that
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may have a defect during divisions. Previously it has been shown by Sakamato et.al.
(1999) that apoptosis occurs at 3 days post-hepatectomy at in rats subjected to70%
PH. Our observation of the decrease in total liver mass at 3 days group of animals is
in parallel with that of previous data.
To determine relatively the expressional changes of the Bcl-2 family members
at transcript levels during liver regeneration, we performed semi-quantitative PCR by
using cyclophilin as internal control. We have isolated total RNA and synthesized
cDNA from all experimental groups.
Our semi-quantitative PCR results in 40% PH were not informative, since we
got different expression levels within the animals of the same time group. This
discrepancy is similar to that of we observed in the mass graphs of these PH groups.
Here, we can again speculate that the difference at the mRNA expression may be due
to extend of the liver resection. Simply, the liver may not respond completely to 40%
hepatectomy.
In our 40% PH groups, however, we observed an interesting data related to the
expression of bcl-2. We found two extra bands at the end of the PCR reaction of bcl-
2  in 40% hepatectomized groups but neither in sham group, normal liver, nor 70%
hepatectomized groups. At this point, it can be speculated that these extra bands may
be the alternatively spliced forms of bcl-2. Normally, bcl-2 has at least two
transcripts, 1,8 and 7,5 kb. bcl-2 gene encodes a protein of 24 kDa from only one of
the transcripts. We do not know, at this point, whether or not these possible spliced
forms are translated into proteins. It is tempting to speculate that bcl-2 gene is
translated into more than one proteins that may have opposite effects on the onset of
apoptosis, since this kind of regulation is seen in other bcl-2 family of genes. bcl-x is
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an example for this, and results in two proteins (Bcl-xL, and Bcl-xS) that have
opposite effects in regulation of apoptosis (Clarke et.al., 1995).
Alternatively, our primer pairs may have recognized a gene or genes other than
bcl-2, non-specifically. According to our searches in GenBank, a known gene in
addition to bcl-2, which can be amplified by our primer pair, is not present.
However, the identification of such a gene or genes will be very important, since
they were differentially expressed during the regeneration process after a 40% PH.
In rats with 70% PH, Masson et.al. (2000) showed an early increase in bcl-2
and bcl-xL and a delayed increase in bad, bak, and bax transcript levels. Also Kren
et.al. (1996) showed the changes of transcript levels of bcl-2, and bcl-xL with a peak
at 6 hr post-hepatectomy, and bax with peaks at 18 hr and 72 hr post-hepatectomy.
In this study, we looked for the changes in the transcript levels of bid, mtd, and
bcl-w in addition to the previously studied bak, bax, bcl-2, and bcl-xL. Furthermore,
an important aspect of our study is the time period under investigation. Most of the
studies used the time groups till 3 days after hepatectomy at most. But we chose a
time spectrum that included time points through the 14 days post-hepatectomy,
which was needed for the completion of the regeneration process.
Our results for 70% PH groups suggested that, the transcript levels of all genes,
except bcl-2, decreased to the half level or 20% of the normal liver levels, just after
hepatectomy. bak and bid expressions made peaks at 18 hr and 3 day groups,
whereas the peak of mtd was seen at 3 days, only. The mRNA level of bax remained
low during regeneration, and it could reach to normal liver levels at 14 days by
completion of the process. bcl-2 transcript levels showed peaks at 8 hr, 24 hr, 3 day,
and 7 day with huge increases. The transcript levels of bcl-w remained low for 5
days, and then increased to normal liver levels at 7 days. bcl-xL made a peak at 8 hr,
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and then decreased to 20% or normal levels at 36 hr. The second peak of bcl-xL
transcripts occurred at 5 days and at 14 days, it decreased again to the level of normal
liver.
When we compared our results of bak, bax, bcl-2, and bcl-xL with the
previously published studies, most of our results about the expression levels of these
genes in 70% PH groups correlate with them. However, the data we obtained for our
sham groups showed that, the surgery itself caused expressional changes of bcl-2
family of genes throughout the investigated time period. The anesthesia, the stress
created during surgery and possible inflammations in the body after surgery may
have effects on the livers of rats. So we can think these expressional changes in the
sham groups as background hepatic responses. Therefore, many of the previous
findings of expressional changes in transcript level found in bcl-2, bcl-xL, bax, and
bak could be speculated as not due to regeneration only, but also due to the effects of
surgical operations.
Since the expressions in sham groups could be considered as background
hepatic response due to surgery, we evaluated our results after subtracting the
transcript levels in the sham groups from the corresponding 70% PH groups’
transcript levels. According to those results, we were able to conclude that the
regeneration process caused decreases in the transcript levels of both pro- and anti-
apoptotic members of bcl-2 family in most of the time points. For the whole period
of 14 days, it was seen that bak, and bcl-2 were the ones, whose transcript levels
changed apparently by the hepatic regeneration process. However, in the 3-days post
hepatectomy, regeneration caused an important level of increase in bak and mtd
transcripts. Actually, this was the time point when the presence of apoptosis was
shown. However, the transcript levels of bcl-2 and bcl-xL were also increased in the
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same time group. Since these expressional changes were detected in mRNA level, we
cannot make speculations about whether they are important in the regulation of the
apoptotic mechanism at this time point. In order to reach a conclusion about this, the
active-state protein levels have to be known. It is clear that, the mRNA level of a
gene may not reflect the protein level of that gene all the time. Kren et.al. showed in
70% PH that the expressions of Bcl-2 and Bcl-xL in protein level did not mimic their
transcript levels, whereas, the protein level patterns of Bax was exactly same with its
mRNA patterns.
In this study, by determining the expressional changes of bcl-2 family members
in transcript level, we can only speculate about the effects of regeneration process on
the control of this family of genes. For having an idea about the roles of bcl-2 family
members on the regulation of the regeneration process, their expressional patterns
have to be shown in protein level, along with their post-translational activation
status.
4.2. FUTURE PERSPECTIVE
As a future perspective, bcl-2 family of genes’ expressional changes in protein
levels and their activation status can be determined for the same set of samples
above. By this information, it will be possible to speculate about the roles of this
family on the regulation of the hepatic regeneration as explained above.
It is known that hepatocytes can undergo cell cycle twice or three times
throughout their life. So it can be expected that, after a 70% PH, with the
regeneration, the hepatocytes spend all their capacity of cellular division. And after a
new hepatic failure, the liver can be expected to fail in a further regeneration so
efficiently in order to correct the deficiency. The cancer development in previously
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hepatectomized rats, which have already regenerated their livers, can be studied in
order to understand the effects of the history of liver pathology on the development
of the cancer. According to our results, the transcript levels of some genes were not
at the normal liver levels at 14-day groups, in which the regeneration process was
completed. Anti-apoptotic bcl-2 and bcl-w transcript levels at 14-day were 3- and 2-
fold of normal levels; and the corresponding level for pro-apoptotic mtd was the half
of the normal values. If a similar pattern of expression in protein levels is also
present, this can be speculated as the regenerated liver would have less tolerance to
apoptotic cell death in future. This means that the regeneration of liver does not mean
the exact return to normal liver status as expected.  A carcinogenic induction will be
expected to be more effective in such a situation.
As mentioned before, liver originates from the endoderm during very early
stages of embryological organogenesis. And after the appearance of the first
differentiated parenchyme and non-parenchyme cells in the embryological liver, it
starts to grow by continuous cellular divisions like in hepatic regeneration.
Therefore, it is possible that during regeneration after a partial hepatectomy, liver
may mimic the events occurred during organogenesis. For the tissue modeling, and
the fine-tuning of the liver size, the embryological or post-natal liver may undergo
apoptosis as seen during regeneration. As a future perspective, the involvement of
the apoptosis during these embryological and post-natal liver development can be
investigated.
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